Camurus AB (CAMRF)
58.00
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Camurus Gross Profit Margin (Quarterly) : 91.74% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 91.74% |
| December 31, 2025 | 90.73% |
| September 30, 2025 | 91.93% |
| June 30, 2025 | 92.98% |
| March 31, 2025 | 91.95% |
| December 31, 2024 | 93.34% |
| September 30, 2024 | 92.24% |
| June 30, 2024 | 92.01% |
| March 31, 2024 | 91.14% |
| December 31, 2023 | 90.27% |
| September 30, 2023 | 90.76% |
| June 30, 2023 | 95.20% |
| March 31, 2023 | 88.71% |
| December 31, 2022 | 88.15% |
| September 30, 2022 | 88.84% |
| June 30, 2022 | 87.56% |
| March 31, 2022 | 86.69% |
| December 31, 2021 | 82.81% |
| September 30, 2021 | 84.21% |
| June 30, 2021 | 82.87% |
| March 31, 2021 | 85.17% |
| December 31, 2020 | 85.25% |
| September 30, 2020 | 85.98% |
| June 30, 2020 | 91.39% |
| Date | Value |
|---|---|
| March 31, 2020 | 79.21% |
| December 31, 2019 | 54.31% |
| September 30, 2019 | 82.60% |
| June 30, 2019 | 65.10% |
| March 31, 2019 | 72.14% |
| December 31, 2018 | 34.65% |
| September 30, 2018 | 93.45% |
| June 30, 2018 | 68.64% |
| March 31, 2018 | 82.27% |
| December 31, 2017 | 67.18% |
| September 30, 2017 | 96.07% |
| June 30, 2017 | 88.89% |
| March 31, 2017 | 93.92% |
| December 31, 2016 | 94.41% |
| September 30, 2016 | 94.96% |
| June 30, 2016 | 95.55% |
| March 31, 2016 | 95.54% |
| December 31, 2015 | 99.71% |
| September 30, 2015 | 97.27% |
| June 30, 2015 | 96.35% |
| March 31, 2015 | 98.50% |
| December 31, 2014 | 99.55% |
| September 30, 2014 | 99.28% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Orexo AB | -86.00% |
| Swedencare AB | 7.60% |
| Moberg Pharma AB | 66.17% |
| Infant Bacterial Therapeutics AB | -- |
| Eli Lilly & Co. | 81.93% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.03% |
| Return on Assets | 15.09% |
| Return on Invested Capital | 16.59% |
| Profit Margin (Quarterly) | 26.98% |
| Operating Margin (Quarterly) | 33.92% |
| Return on Net Operating Assets | 78.08% |